PDCD1 and Sepsis: During early sepsis, activation of the PD-1/PD-L1 pathway leads to innate immune cell dysfunction, and treatment with anti-PD-L1 antibodies can reverse monocyte dysfunction and inhibit T-cell apoptosis (56).